Insider · CIK 0001314596

Katkin Keith

Reports to the SEC for 7 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001314596

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-30	EBSEmergent BioSolutions Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+11.3K sh	—	—	11,296
2026-04-30	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+25.3K sh	—	—	111,775
2026-04-30	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−15.5K sh	$8.28	−$128K	96,294
2026-02-04	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+24K sh	—	—	124,000
2026-01-10	ELDNEledon Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,575 sh	—	—	0
2026-01-10	ELDNEledon Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,575 sh	—	—	8,575
2025-05-23	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−7,844 sh	$6.30	−$49.4K	86,431
2025-05-19	SNDXSyndax Pharmaceuticals IncP Purchase	Director	PPurchase	+10K sh	$9.11	+$91.1K	100,000
2025-04-30	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+34.4K sh	—	—	94,275
2025-04-30	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.8K sh	—	—	41,572
2025-02-05	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+25K sh	—	—	90,000
2025-01-10	ELDNEledon Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+77.2K sh	—	—	77,175
2025-01-10	ELDNEledon Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+8,575 sh	—	—	8,575
2024-05-23	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+17.4K sh	—	—	59,872
2024-05-23	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.7K sh	—	—	25,748
2024-02-07	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+17K sh	—	—	65,000
2023-05-25	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+33.8K sh	—	—	42,442
2023-05-01	ELDNEledon Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+752K sh	—	—	752,185
2023-02-02	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+16K sh	—	—	48,000
2023-02-01	ELDNEledon Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-10-06	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,117 sh	—	—	0
2022-10-06	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20.8K sh	—	—	0
2022-10-06	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−9,117 sh	$25.90	−$236K	32,000
2022-10-06	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+9,117 sh	$8.93	+$81.4K	41,117
2022-10-06	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−20.8K sh	$25.90	−$538K	32,000
2022-10-06	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+20.8K sh	$7.88	+$164K	52,782
2022-10-04	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−137 sh	—	—	0
2022-10-04	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−223 sh	—	—	0
2022-10-04	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−223 sh	$25.00	−$5,575	32,000
2022-10-04	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+223 sh	$8.93	+$1,991.39	32,223
2022-10-04	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−137 sh	$25.00	−$3,425	32,000
2022-10-04	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+137 sh	$7.88	+$1,079.56	32,137
2022-10-03	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+13 sh	$8.93	+$116.09	32,013
2022-10-03	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−167 sh	$25.00	−$4,175	32,000
2022-10-03	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+167 sh	$7.88	+$1,315.96	32,167
2022-10-03	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−167 sh	—	—	0
2022-10-03	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−13 sh	—	—	0
2022-10-03	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−13 sh	$25.00	−$325	32,000
2022-09-30	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−647 sh	$25.07	−$16.2K	32,000
2022-09-30	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+647 sh	$8.93	+$5,777.71	32,647
2022-09-30	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,914 sh	—	—	0
2022-09-30	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−647 sh	—	—	0
2022-09-30	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−2,914 sh	$25.07	−$73.1K	32,000
2022-09-30	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+2,914 sh	$7.88	+$23K	34,914
2022-04-02	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+8,595 sh	—	—	8,595
2022-02-02	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+16K sh	—	—	32,000
2022-02-01	ELDNEledon Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-05-19	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-05-19	RIGLRIGEL PHARMACEUTICALS INCA Award	Director	AAward	+25K sh	—	—	25,000
2021-02-03	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+16K sh	—	—	16,000

Recent filings

Accepted (ET)
May 44
Katkin Keith0001314596-26-000002
SEC(opens sec.gov)
Feb 64
Katkin Keith0001193125-26-041192
SEC(opens sec.gov)
Jan 164
Katkin Keith0001193125-26-015486
SEC(opens sec.gov)
May 284
Katkin Keith0001367644-25-000136
SEC(opens sec.gov)
May 194
Katkin Keith0000950170-25-074289
SEC(opens sec.gov)
May 24
Katkin Keith0001367644-25-000106
SEC(opens sec.gov)
Feb 74
Katkin Keith0000950170-25-016363
SEC(opens sec.gov)
Jan 134
Katkin Keith0000950170-25-004922
SEC(opens sec.gov)
May 284
Katkin Keith0001367644-24-000089
SEC(opens sec.gov)
Feb 94
Katkin Keith0001562180-24-001218
SEC(opens sec.gov)
May 304
Katkin Keith0001367644-23-000105
SEC(opens sec.gov)
May 24
Katkin Keith0001209191-23-026728
SEC(opens sec.gov)
Feb 34
Katkin Keith0001562180-23-000943
SEC(opens sec.gov)
Feb 24
Katkin Keith0001209191-23-006339
SEC(opens sec.gov)

Companies

Address

300 PROFESSIONAL DRIVE

GAITHERSBURG, MD, 20879